Latest updates for Ad And Mci

Fresh curated links around AD and MCI are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Acupuncture plus donepezil in AD 2026
  • What is Alzheimer’s Disease (AD)?
  • PM20D1 Creates N-oleoyl-Leucine to Improve Clearance of Amyloid-β Aggregates by Microglia

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

bmas.blog /3 weeks ago

Acupuncture plus donepezil in AD 2026

Stimulated by Kong et al 2026.[1] AD – Alzheimer’s diseaseRCT – randomised controlled trialIF – impact factorCDR – clinical dementia ratingMA – manual acupunctureEA – electroacupun...

Read source
womenfitness.net /5 days ago

What is Alzheimer’s Disease (AD)?

Causes Stages Symptoms Diagnosis Treatment Drug therapy Diet Management Exercise Complementary therapy What is Alzheimer’s Disease (AD): Alzheimer’s disease is an incurable, progre...

Read source
fightaging.org /1 day ago

PM20D1 Creates N-oleoyl-Leucine to Improve Clearance of Amyloid-β Aggregates by Microglia

Researchers here note a mechanism that encourages the innate immune cells known as microglia to better clear amyloid-β in the aging brain. The protein PM20D1 acts in the formation...

Read source
medcitynews.com /1 month ago

The Key Biomarkers Changing How and When We Diagnose Alzheimer’s Disease

Innovations in biomarker science, particularly in cerebrospinal fluid (CSF) and blood, are expanding Alzheimer’s testing beyond specialty care. The post The Key Biomarkers Changin...

Read source
psychologytoday.com /1 month ago

Decoding Alzheimer’s Disease

Should you receive a diagnosis of AD, many factors shape how symptoms unfold. The brain, even when under siege, retains an astonishing resilience.

Read source
thefdalawblog.com /1 month ago

HPM’s Allyson Mullen and Jeff Gibbs to Speak at AMDM’s Annual Meeting

On April 22 and 23, 2026, the Association of Medical Diagnostic Manufacturers will hold its Annual Meeting at the Canopy by Hilton in Bethesda, MD.  The day and a half meeting, whi...

Read source
hitconsultant.net /2 weeks ago

How Lucent and Tempus Are Using AI to Spot Alzheimer’s Earlier

What You Should Know Lucent Diagnostics (a brand of Quanterix) and Tempus AI have announced a strategic collaboration to integrate Alzheimer’s blood-based biomarker testing into ro...

Read source
jns-journal.com /1 month ago

Diagnostic adjudication of potential participants with chronic inflammatory demyelinating polyradiculoneuropathy in the...

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare, acquired, immune-mediated polyneuropathy that is commonly misdiagnosed. The global, pivotal ADHERE trial...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Ad And Mci

bmas.blog

Recent coverage from public sources
Public source

hitconsultant.net

Recent coverage from public sources
Public source

medcitynews.com

Recent coverage from public sources
Public source

fightaging.org

Recent coverage from public sources
Public source

jns-journal.com

Recent coverage from public sources
Public source

psychologytoday.com

Recent coverage from public sources
Public source